V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006836 | 330003586 | 1.62 | 18.1 | Neo-adjuvant (N) | 2013-06-25 | 2013-07-03 | Mifamurtide weeks 1-12 | N | N | 330005221 | MIFAMURTIDE |
| 330006837 | 330003587 | null | 80.5 | Curative (C) | 2013-10-05 | 2013-10-05 | MIFAMURTIDE | Y | N | 330005241 | MIFAMURTIDE |
| 330006840 | 330003591 | 0 | 91.9 | Curative (C) | 2014-09-06 | 2015-02-07 | METHOTREXATE | Y | N | 330005262 | METHOTREXATE |
| 330006841 | 330003593 | 1.66 | 17.4 | Neo-adjuvant (N) | 2016-01-10 | 2016-01-10 | DOXORUBICIN | 2 | N | 330005269 | DOXORUBICIN |
| 330006842 | 330003594 | null | 53.4 | Neo-adjuvant (N) | null | 2013-07-31 | DOXORUBICIN | Y | null | 330005271 | DOXORUBICIN |
| 330006843 | 330003595 | 0 | 51.2 | null | null | 2013-09-27 | DOXORUBICIN | Y | null | 330005281 | DOXORUBICIN |
| 330006844 | 330003596 | 1.61 | 46 | Neo-adjuvant (N) | 2015-08-23 | 2016-10-05 | Methotrexate Intermed dose (1g/m2) | N | N | 330005285 | METHOTREXATE |
| 330006845 | 330003597 | 1.6 | 28.6 | Palliative (P) | 2017-03-07 | 2017-03-07 | Trial Unspecified | Y | N | 330005287 | TRIAL |
| 330006846 | 330003599 | 1.75 | null | Adjuvant (A) | 2015-08-26 | 2015-11-03 | Cisplatin | null | N | 330005288 | CISPLATIN |
| 330006847 | 330003599 | null | 77.1 | Neo-adjuvant (N) | 2016-10-13 | 2017-03-31 | OST Mifamurtide | 02 | N | 330005288 | MIFAMURTIDE |
| 330006848 | 330003600 | null | 47.8 | Neo-adjuvant (N) | null | 2016-07-15 | MIFAMURTIDE | Y | null | 330005294 | MIFAMURTIDE |
| 330006849 | 330003600 | null | null | Curative (C) | 2017-03-31 | 2017-08-03 | Mifamurtide weeks 13-36 | N | N | 330005294 | MIFAMURTIDE |
| 330006850 | 330012350 | 0 | 77.1 | Palliative (P) | null | 2014-06-02 | METHOTREXATE | N | null | 330005300 | METHOTREXATE |
| 330006851 | 330003605 | 0 | null | Neo-adjuvant (N) | 2014-08-31 | 2014-09-01 | EW EuroEwing 2012 Arm B VDC | 02 | N | 330005313 | TRIAL |
| 330006852 | 330003606 | 1.74 | null | Curative (C) | 2018-06-05 | 2018-06-05 | Trial Unspecified | Y | N | 330005315 | TRIAL |
| 330006853 | 330007936 | 1.68 | 59 | Palliative (P) | 2014-02-21 | 2014-02-21 | Trial Unspecified | N | N | 330005325 | TRIAL |
| 330006854 | 330003610 | null | 88 | Palliative (P) | 2015-05-04 | 2015-05-04 | Trial Unspecified | N | N | 330005334 | TRIAL |
| 330006855 | 330013153 | 1.76 | 84.4 | Curative (C) | 2013-11-20 | 2014-01-10 | Cisplatin | Y | N | 330005342 | CISPLATIN |
| 330006856 | 330003612 | 1.66 | 92.1 | Curative (C) | 2015-04-20 | 2015-04-21 | Trial Unspecified | null | N | 330005358 | TRIAL |
| 330006857 | 330003614 | 1.65 | 112 | Adjuvant (A) | 2018-02-14 | 2018-02-14 | EW EuroEwing 2012 Arm B IE | Y | N | 330005358 | TRIAL |
| 330006858 | 330003614 | 1.62 | 18 | Neo-adjuvant (N) | 2015-03-08 | 2015-03-14 | Methotrexate 25-50mg/m2 iv 7day | Y | N | 330005358 | METHOTREXATE |
| 330006859 | 330003620 | 1.82 | 59.6 | Curative (C) | 2015-10-09 | 2016-03-29 | Trial Unspecified | N | N | 330005399 | TRIAL |
| 330006860 | 330007942 | 1.74 | 32.5 | Neo-adjuvant (N) | 2016-07-11 | 2016-07-11 | DOXORUBICIN | N | N | 330005418 | DOXORUBICIN |
| 330006861 | 330003622 | 0 | null | Neo-adjuvant (N) | 2018-05-06 | 2018-07-03 | METHOTREXATE | N | N | 330005420 | METHOTREXATE |
| 330006862 | 330003623 | null | 95.1 | Curative (C) | 2013-08-22 | 2013-08-29 | EW EuroEwing 2012 Arm B VDC | Y | N | 330005439 | TRIAL |
| 330006863 | 330003624 | 1.78 | 71 | Not known (9) | 2017-11-17 | 2018-02-03 | Cisplatin 7 day | N | Y | 330005446 | CISPLATIN |
| 330006864 | 330003625 | null | 47.8 | Curative (C) | 2015-08-29 | 2015-11-23 | Cisplatin | 2 | N | 330005452 | CISPLATIN |
| 330006865 | 330007945 | 1.9 | null | Palliative (P) | 2016-06-23 | 2016-06-23 | EW EuroEwing 2012 Arm A VAI | Y | N | 330005461 | TRIAL |
| 330006866 | 330003628 | 1.82 | null | Curative (C) | 2013-06-14 | 2013-07-03 | Trial Unspecified | N | null | 330005470 | TRIAL |
| 330006868 | 330003629 | 1.58 | 77.9 | null | 2014-04-13 | 2014-04-19 | Trial Unspecified | N | N | 330005491 | TRIAL |
| 330006869 | 330003630 | 1.74 | 49.8 | Curative (C) | 2016-08-17 | 2016-08-17 | Trial Unspecified | Y | N | 330005499 | TRIAL |
| 330006870 | 330003630 | 1.46 | 77.4 | Curative (C) | 2017-12-01 | 2017-12-15 | Trial Unspecified | Y | N | 330005499 | TRIAL |
| 330006871 | 330003635 | 1.77 | 53.2 | Disease modification (D) | 2018-08-01 | 2018-08-04 | Trial Unspecified | N | null | 330005520 | TRIAL |
| 330006872 | 330003636 | 1.66 | 19.5 | Neo-adjuvant (N) | null | 2015-10-17 | OST Mifamurtide | N | null | 330005522 | MIFAMURTIDE |
| 330006873 | 330007956 | 0 | 72.6 | Curative (C) | 2013-10-14 | 2013-10-15 | Cisplatin | 2 | N | 330005545 | CISPLATIN |
| 330006874 | 330003638 | 1.82 | 74.7 | Palliative (P) | 2015-11-23 | 2016-05-16 | LAMB TRIAL | N | null | 330005548 | TRIAL |
| 330006875 | 330003638 | null | 85 | Curative (C) | 2014-10-25 | 2014-11-19 | Trial Unspecified | Y | Y | 330005548 | TRIAL |
| 330006876 | 330003641 | null | 79.7 | null | null | 2016-12-20 | Cisplatin 7 day | null | null | 330005555 | CISPLATIN |
| 330006877 | 330007958 | 1.54 | 85.1 | Adjuvant (A) | 2016-12-31 | 2017-11-14 | METHOTREXATE | Y | N | 330005564 | METHOTREXATE |
| 330006878 | 330003643 | 1.61 | null | Curative (C) | 2017-08-14 | 2017-09-24 | Trial Unspecified | 1 | N | 330005564 | TRIAL |
| 330006879 | 330007960 | 0 | 53.4 | Curative (C) | null | 2015-05-03 | Cisplatin | null | null | 330005584 | CISPLATIN |
| 330006880 | 330007960 | 2 | 80.5 | Palliative (P) | 2015-11-28 | 2015-12-17 | Trial Unspecified | Y | N | 330005584 | TRIAL |
| 330006881 | 330003647 | null | 85 | Palliative (P) | 2014-09-07 | 2015-01-16 | Trial Unspecified | N | null | 330005595 | TRIAL |
| 330006882 | 330003647 | 1.58 | null | Disease modification (D) | 2013-12-21 | 2013-12-22 | EW EuroEwing 2012 Arm B IE | Y | Y | 330005595 | TRIAL |
| 330006883 | 330003647 | 1.72 | 107.7 | Neo-adjuvant (N) | 2014-07-30 | 2014-07-31 | DOXORUBICIN | Y | N | 330005595 | DOXORUBICIN |
| 330006884 | 330012354 | null | 37 | Neo-adjuvant (N) | null | 2017-09-23 | OST Mifamurtide | null | null | 330005613 | MIFAMURTIDE |
| 330006885 | 330012354 | 1.81 | null | Disease modification (D) | 2017-05-23 | 2017-05-23 | EW EuroEwing 2012 Arm B IE | 02 | N | 330005613 | TRIAL |
| 330006886 | 330003651 | 1.83 | 58.2 | Palliative (P) | 2014-05-15 | 2014-05-16 | OST Euramos 1 Closed Trial - IE | N | Y | 330005616 | TRIAL |
| 330006887 | 330003652 | 1.7 | 72.4 | Curative (C) | 2016-12-11 | 2016-12-14 | DOXORUBICIN | N | Y | 330005625 | DOXORUBICIN |
| 330006888 | 330010326 | 1.6 | 0 | Curative (C) | 2017-07-21 | 2017-10-07 | METHOTREXATE | null | null | 330005637 | METHOTREXATE |